Previous 10 | Next 10 |
SPDR S&P Pharmaceuticals ETF (NYSEARCA: XPH ) declares quarterly distribution of $0.0683 . 30-Day SEC Yield of 0.60%. Payable June 27; for shareholders of record June 25; ex-div June 24. Press Release More news on: SPDR S&P Pharmaceuticals ETF, Dividend News, , News on ETF...
By Andy Acker, CFA and Denny Fish Portfolio Managers Andy Acker and Denny Fish explore disruptive forces in healthcare and technology. Disruption is being felt across industries and geographies and proving to be a differentiator in the long-term performance of investors' portfolios. Su...
By Tony DeSpirito Markets tend to focus on one risk at a time, and it’s fragile U.S.-China relations that are front and center now. New blog contributor Tony DeSpirito offers up two potential takeaways for equity investors. Headlines over the U.S.-China trade dispute have been p...
Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to stay informed about what companies are leading the industry. Pharma ETFs are key for investors who want to trade in a set of assets instead of individual companies. For novic...
In lockstep with the U.S., Canadian officials are poised to implement a new initiative aimed at corralling high prescription drug costs, despite an offer by drug makers to pay C$8.6B (US$6.6B) over 10 years, freeze prices or reduce the cost of treating rare diseases. More news on: ProSha...
Following through on its commitment to promote lower drug costs, the Trump administration announces that pharmaceutical and biotech companies will be required to disclose prices in television commercials for medications covered by Medicare that cost more than $35 for a month's supply (mean...
Since last Tuesday, when UnitedHealth Group ( UNH )’s discussion of Medicare-for-All spooked investors, health care stocks have dropped 5%, while the market was almost flat over the same time period. In our opinion, there is a good reason for healthcare investors to be fearful. We wil...
Investors in biotechs and biopharma firms appear to have intensified their profit-taking after the Q1 run-up, stoked, no doubt, from the sour mood in Congress over high drug prices and the Trump administration's stated priority to tackle the problem. More news on: SPDR Biotech ETF, SPDR S&...
Pharmaceutical companies are continuing to defy political pressure from both Democrats and Republicans by raising the prices of almost 3,000 drugs in the U.S. in the first three months of this year. More news on: Health Care Select Sect SPDR ETF, iShares U.S. Healthcare ETF, Vanguard Hea...
SPDR S&P 600 Small Cap Growth ETF (NYSEARCA: SLYG ) - $0.2134 . 30-Day SEC Yield of 1.05%. SPDR S&P 500 Small Cap Growth ETF (NYSEARCA: SPYG ) - $0.1222 . 30-Day SEC Yield of 1.43%. SPDR S&P 500 Value ETF (NYSEARCA: SPYV ) - $0.1753 . 30-Day SEC Yield of 2.44%. SPDR S&am...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...